In multiple sclerosis (MS), a PPARg polymorphism has been shown to be linked to the disease; in fact, the Ala/Ala genotype of the Pro12Ala PPARg polymorphism is associated with a delayed onset of disease [40]. Here, PPARG is linked to myeloid sarcoma.